ZWJ Investment Counsel’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.9M Buy
341,420
+3,260
+1% +$701K 2.78% 7
2026
Q1
$73.5M Buy
338,160
+2,820
+0.8% +$626K 2.65% 9
2025
Q4
$76.6M Sell
335,340
-2,452
-0.7% -$559K 2.76% 7
2025
Q3
$78.2M Buy
337,792
+3,805
+1% +$775K 2.76% 7
2025
Q2
$62M Buy
333,987
+422
+0.1% +$78.4K 2.3% 10
2025
Q1
$69.9M Buy
333,565
+793
+0.2% +$154K 2.84% 4
2024
Q4
$59.1M Buy
332,772
+5,887
+2% +$1.08M 2.44% 9
2024
Q3
$64.6M Buy
326,885
+776
+0.2% +$145K 2.64% 8
2024
Q2
$55.9M Buy
326,109
+8,330
+3% +$1.38M 2.46% 9
2024
Q1
$57.9M Buy
317,779
+543
+0.2% +$93.6K 2.63% 7
2023
Q4
$49.2M Buy
317,236
+561
+0.2% +$81.8K 2.53% 8
2023
Q3
$47.2M Sell
316,675
-130
-0% -$19.1K 2.62% 8
2023
Q2
$42.7M Buy
316,805
+23,703
+8% +$3.48M 2.23% 11
2023
Q1
$46.7M Buy
293,102
+10,189
+4% +$1.56M 2.58% 7
2022
Q4
$45.7M Buy
282,913
+4,363
+2% +$669K 2.58% 6
2022
Q3
$37.4M Buy
278,550
+3,376
+1% +$484K 2.35% 7
2022
Q2
$42.1M Buy
275,174
+110
+0% +$16.8K 2.46% 7
2022
Q1
$44.6M Buy
275,064
+902
+0.3% +$131K 2.36% 8
2021
Q4
$37.1M Buy
274,162
+6,980
+3% +$825K 1.9% 19
2021
Q3
$28.8M Buy
267,182
+8,239
+3% +$941K 1.63% 22
2021
Q2
$29.2M Buy
258,943
+133,845
+107% +$15.1M 1.69% 23
2021
Q1
$13.5M Buy
125,098
+83,677
+202% +$8.95M 0.83% 50
2020
Q4
$4.44M Buy
41,421
+4,758
+13% +$457K 0.3% 59
2020
Q3
$3.21M Sell
36,663
-1,770
-5% -$167K 0.26% 59
2020
Q2
$3.77M Sell
38,433
-61,655
-62% -$5.43M 0.33% 54
2020
Q1
$7.63M Buy
100,088
+871
+0.9% +$74.2K 0.68% 44
2019
Q4
$8.79M Buy
99,217
+61,531
+163% +$5.11M 0.59% 53
2019
Q3
$2.85M Buy
37,686
+1,000
+3% +$68.6K 0.22% 62
2019
Q2
$2.67M Buy
36,686
+6,071
+20% +$477K 0.21% 65
2019
Q1
$2.47M Buy
30,615
+1,135
+4% +$92.9K 0.2% 66
2018
Q4
$2.72M Buy
29,480
+314
+1% +$27.6K 0.26% 64
2018
Q3
$2.76M Buy
29,166
+960
+3% +$91K 0.22% 61
2018
Q2
$2.61M Hold
28,206
0.23% 62
2018
Q1
$2.67M Sell
28,206
-5,675
-17% -$623K 0.24% 61
2017
Q4
$3.28M Sell
33,881
-1,102
-3% -$104K 0.26% 63
2017
Q3
$3.11M Buy
34,983
+1,442
+4% +$110K 0.24% 66
2017
Q2
$2.43M Sell
33,541
-4,218
-11% -$284K 0.19% 72
2017
Q1
$2.46M Buy
37,759
+6,529
+21% +$410K 0.2% 74
2016
Q4
$1.96M Sell
31,230
-3,669
-11% -$224K 0.19% 70
2016
Q3
$2.2M Sell
34,899
-445
-1% -$28.8K 0.22% 68
2016
Q2
$2.19M Buy
35,344
+1,150
+3% +$70.1K 0.22% 68
2016
Q1
$1.95M Sell
34,194
-75
-0.2% -$4.18K 0.21% 68
2015
Q4
$2.03M Buy
34,269
+300
+0.9% +$17.3K 0.22% 73
2015
Q3
$1.85M Sell
33,969
-1,300
-4% -$84.6K 0.21% 69
2015
Q2
$2.37M Buy
35,269
+800
+2% +$52.2K 0.25% 70
2015
Q1
$2.02M Buy
34,469
+7,019
+26% +$424K 0.21% 72
2014
Q4
$1.8M Sell
27,450
-6,821
-20% -$430K 0.18% 74
2014
Q3
$1.98M Buy
34,271
+1,809
+6% +$100K 0.21% 74
2014
Q2
$1.83M Sell
32,462
-324
-1% -$17K 0.2% 74
2014
Q1
$1.69M Buy
32,786
+727
+2% +$36.7K 0.2% 75
2013
Q4
$1.69M Buy
32,059
+399
+1% +$19.6K 0.19% 76
2013
Q3
$1.42M Sell
31,660
-11,371
-26% -$504K 0.18% 73
2013
Q2
$1.78M Buy
+43,031
New +$1.88M 0.24% 70

Other funds holding ABBV

ZWJ Investment Counsel's ABBV Position: Q2 2026 in Review

ZWJ Investment Counsel increased its AbbVie (ABBV) stake by 0.96% in Q2 2026, buying an estimated $701K and bringing the position to 341,420 shares worth $85.9M. The position accounts for 2.78% of the portfolio, ranked #7.

ZWJ Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ZWJ Investment Counsel held 341,420 shares of AbbVie worth $85.9M as of Q2 2026.
  • ZWJ Investment Counsel bought 3,260 AbbVie shares in Q2 2026, an estimated $701K.
  • AbbVie made up 2.78% of ZWJ Investment Counsel's portfolio in Q2 2026, its #7 holding.
  • ZWJ Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.